# FDA 483 - Vet Pharma Friesoythe GmbH - February 04, 2025

Source: https://www.globalkeysolutions.net/records/483/vet-pharma-friesoythe-gmbh/f52fb1b7-f9e6-4c04-a846-0ac079c7d8fd

> FDA 483 for Vet Pharma Friesoythe GmbH on February 04, 2025. Product: veterinary. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Vet Pharma Friesoythe GmbH
- Inspection Date: 2025-02-04
- Product Type: veterinary
- Office Name: Office of Inspections and Investigations
- Summary: Vet Pharma Friesoythe GmbH, a finished animal drug manufacturer in Friesoythe, Germany, was cited for three significant issues during an FDA inspection. Observations included inadequate validation of sterile drug product manufacturing processes, deficiencies in cleaning and disinfection procedures for processing areas, and insufficient laboratory records to ensure the accuracy and reliability of sterility test methods. These findings indicate a moderate level of severity regarding quality control and sterile manufacturing practices.

## Related Documents

- [483 - 2023-03-24](https://www.globalkeysolutions.net/records/483/vet-pharma-friesoythe-gmbh/b6e21207-217c-461c-aa01-4d3818d9852e)

## Related Officers

- [Microbiologist](https://www.globalkeysolutions.net/people/michael-t-cyrus/30e497e1-2c17-4dd7-9a5b-251771cf4266)
- [Quality System Specialist](https://www.globalkeysolutions.net/people/jose-e-melendez/75bd6083-14a4-4bd2-a0e5-9946d4dd37e1)

Company: https://www.globalkeysolutions.net/companies/vet-pharma-friesoythe-gmbh/d5ae589a-9f1d-41b9-8cc8-1b3113f07a7d

Office: https://www.globalkeysolutions.net/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8